quinoxalines has been researched along with Bladder Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fischer, I; Mitsui, T; Neuhuber, B | 1 |
| Akino, H; Komatsu, K; Mizuno, H; Namiki, M; Tanase, K; Yokoyama, O | 1 |
2 other study(ies) available for quinoxalines and Bladder Diseases
| Article | Year |
|---|---|
Acute administration of AMPA/Kainate blocker combined with delayed transplantation of neural precursors improves lower urinary tract function in spinal injured rats.
Topics: Animals; Calcitonin Gene-Related Peptide; Diagnostic Imaging; Disease Models, Animal; Embryo, Mammalian; Excitatory Amino Acid Antagonists; Female; Flow Cytometry; Motor Activity; Neural Stem Cells; Quinoxalines; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Recovery of Function; Serotonin; Spinal Injuries; Urinary Bladder Diseases; Urination; Urodynamics | 2011 |
Role of glutamate receptors in the development and maintenance of bladder overactivity after cerebral infarction in the rat.
Topics: Animals; Cerebral Infarction; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Glutamate; Urinary Bladder Diseases | 2004 |